Sun Pharmaceutical Industries Limited has released its confirmation certificate regarding the dematerialization of shares for the quarter ended 31 March 2026. The process was verified by the company’s Registrar and Share Transfer Agent, MUFG Intime India Pvt. Ltd., ensuring all regulatory standards for shareholder records were met during this period.
Quarterly Compliance Update
Sun Pharmaceutical Industries Limited has completed its review of the dematerialization activities for the fourth quarter of the financial year, covering the period ending 31 March 2026. The company, in coordination with its Registrar and Share Transfer Agent, MUFG Intime India Pvt. Ltd., has confirmed the successful processing of all securities received for conversion into electronic form.
Verification of Shareholder Records
The verification process ensured that all securities received from depository participants were duly accepted or rejected within the mandated timelines. Following strict internal protocols, all physical certificates submitted for dematerialization were mutilated and cancelled after verification. Furthermore, the records in the register of members have been updated to reflect the current registered owners, maintaining the accuracy of the company’s shareholding data.
Market Listing Status
It has been confirmed that the securities processed for dematerialization have been formally listed on the relevant stock exchanges. This ensures that the dematerialized shares maintain the same liquidity and trading status as the company’s earlier issued securities, providing consistent service to all stakeholders.
Source: BSE
